Teva announces U.S. FDA approval of three-times-a-week COPAXONE® (glatiramer acetate injection) 40mg/mL
Market Watch, The Wall Street Journal, 28 Jan 2014
Accessed on 30 Jan 2014 from http://www.marketwatch.com/story/teva-announces-us-fda-approval-of-three-times-a-week-copaxone-glatiramer-acetate-injection-40mgml-2014-01-28?reflink=MW_news_stmp.